FEB 27, 2015 9:37 AM PST

Big Bad Bug

ATLANTA -- A nasty intestinal bug sickens nearly twice as many Americans each year as was previously thought, according to the largest U.S. study to look at the problem.
The germ - Clostridium difficile, or C. diff. - flourishes in the gut after antibiotics kill off other bacteria and causes diarrhea. It can be severe and is blamed for about 15,000 deaths annually - mostly in people over the age of 65.
Patients who have been in the hospital and have taken antibiotics are greatest at risk for developing C. diff. infections.
Gram-positive C. difficile bacteria
For years, it's been seen as a growing problem, and health officials have made it a focus in a campaign to reduce infections picked up in the hospital.
The new study, which was led by the Centers for Disease Control and Prevention and published in Thursday's New England Journal of Medicine, found that in 2011, at least 453,000 Americans got sick from C. diff. The number probably would be more like 600,000 if the most sophisticated tests had been used in every case. Researchers previously had put the number of annual cases at around 250,000. The new study cast a wider net than earlier research, and used information from labs in selected counties in 10 states.

"C. difficile infections cause immense suffering and death for thousands of Americans each year," CDC director Dr. Tom Frieden said in a press statement. "These infections can be prevented by improving antibiotic prescribing and by improving infection control in the health care system."
C. diff. is found in the colon and can cause diarrhea and a more serious intestinal condition known as colitis. It is spread by spores in feces. The spores are difficult to kill with most conventional household cleaners or alcohol-based hand sanitizers.

Like earlier studies, the new research suggests that about two-thirds of C. diff.cases occur in hospitals or nursing homes or in recently discharged patients. Of the other third, researchers say a majority had visited a medical facility like a doctor's office or dentist in the 12 weeks before their diagnosis.
C. diff. is treated with antibiotics, but health officials are especially concerned about the growing prevalence of antibiotic resistance. Experimental treatment alternatives involving fecal transplants from a healthy person, perhaps in the form of a "poop pill" have shown promise and may work more effectively than current drugs by reintroducing healthy bacteria that fight the infection.

As officials are getting a better handle on the size of America's C. diff. problem, there are some signs of progress. Many hospitals and other health care facilities have been stepping up efforts to more thoroughly clean rooms to prevent C. diff.from spreading to other patients. There also have been programs to use antibiotics more sparingly.

In a report last month, the CDC found a 10 percent decrease from 2011 to 2013 inC. diff. illnesses that started in the hospital. "We are seeing some declines, and that's encouraging," said Dr. L. Clifford McDonald, a CDC researcher who co-authored the paper.

About the Author
  • I'm a writer living in the Boston area. My interests include cancer research, cardiology and neuroscience. I want to be part of using the Internet and social media to educate professionals and patients in a collaborative environment.
You May Also Like
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
China Begins Trials for Antiviral Drug to Tackle Coronavirus
So far, coronavirus has infected over 31,493 people globally, and has killed 638. Although 1,563 people have reportedly recovered, due to its fast-spreadin...
FEB 19, 2020
FEB 19, 2020
Cases of Coronavirus SARS-CoV-2 Start to Rise Outside of China
The novel coronavirus that recently emerged in Hubei province, China is called SARS-CoV-2, and it can cause a wide range of symptoms....
FEB 21, 2020
FEB 21, 2020
Longer Sitting Times Linked to Developing Heart Disease
Longer sitting times has been associated with a higher risk of developing heart disease among overweight and obese women following menopause. For the study...
FEB 24, 2020
Health & Medicine
FEB 24, 2020
Breast Cancer Screening, without the Radiation
Researchers from the University of Waterloo have developed a prototype of a novel technology that is capable of screening for breast cancer without using r...
FEB 24, 2020
FEB 24, 2020
Could NRF2 trigger hepatomegaly?
Research published today in the Journal of Hepatology suggests that the protein responsible for antioxidant defenses in humans may adversely affect th...
FEB 27, 2020
Drug Discovery & Development
FEB 27, 2020
New Drug Shows Promise in Treating Chronic Cough
Between 4% and 10% of adults around the world have an unexplainable chronic cough that has lasted for over 8 weeks. Although no treatments are currently av...
Loading Comments...